These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 9283990)

  • 21. Management of diabetic gastroparesis.
    Mukhopadhyay P; Basu AK
    J Indian Med Assoc; 2005 Mar; 103(3):184, 186. PubMed ID: 16173296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrogastrography in patients with gastroparesis and effect of long-term cisapride.
    Rothstein RD; Alavi A; Reynolds JC
    Dig Dis Sci; 1993 Aug; 38(8):1518-24. PubMed ID: 8344110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of cisapride on gastric emptying of indigestible solids in patients with gastroparesis diabeticorum. A comparison with metoclopramide and placebo.
    Feldman M; Smith HJ
    Gastroenterology; 1987 Jan; 92(1):171-4. PubMed ID: 3781184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis.
    Soykan I; Sarosiek I; McCallum RW
    Am J Gastroenterol; 1997 Jun; 92(6):976-80. PubMed ID: 9177513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigational drug therapies for the treatment of gastroparesis.
    Sanger GJ; Pasricha PJ
    Expert Opin Investig Drugs; 2017 Mar; 26(3):331-342. PubMed ID: 28127997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis.
    Tack J; Depoortere I; Bisschops R; Verbeke K; Janssens J; Peeters T
    Aliment Pharmacol Ther; 2005 Nov; 22(9):847-53. PubMed ID: 16225494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Gastroparesis and its treatment options].
    Igaz P; Tulassay Z
    Orv Hetil; 2008 Mar; 149(9):393-8. PubMed ID: 18292033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and Safety of Relamorelin in Diabetics With Symptoms of Gastroparesis: A Randomized, Placebo-Controlled Study.
    Camilleri M; McCallum RW; Tack J; Spence SC; Gottesdiener K; Fiedorek FT
    Gastroenterology; 2017 Nov; 153(5):1240-1250.e2. PubMed ID: 28760384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of idiopathic, diabetic and miscellaneous gastroparesis with cisapride.
    Champion MC
    Scand J Gastroenterol Suppl; 1989; 165():44-52; discussion 52-3. PubMed ID: 2690324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of EM574 and cisapride on gastric contractile and emptying activity in normal and drug-induced gastroparesis in dogs.
    Tanaka T; Mizumoto A; Mochiki E; Suzuki H; Itoh Z; Omura S
    J Pharmacol Exp Ther; 1998 Nov; 287(2):712-9. PubMed ID: 9808701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Idiopathic gastroparesis.
    Parkman HP
    Gastroenterol Clin North Am; 2015 Mar; 44(1):59-68. PubMed ID: 25667023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized clinical trial: a controlled pilot trial of the 5-HT4 receptor agonist revexepride in patients with symptoms suggestive of gastroparesis.
    Tack J; Rotondo A; Meulemans A; Thielemans L; Cools M
    Neurogastroenterol Motil; 2016 Apr; 28(4):487-97. PubMed ID: 27010235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of cisapride on gastric emptying in diabetic patients without gastrointestinal symptoms.
    Kasai S; Tanaka K; Machimura H; Takeda H; Kaneshige H; Sakai H; Harasawa S
    Tokai J Exp Clin Med; 1991 Jul; 16(2):97-102. PubMed ID: 1780919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetic gastroparesis. A critical reappraisal of new treatment strategies.
    Drenth JP; Engels LG
    Drugs; 1992 Oct; 44(4):537-53. PubMed ID: 1281070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis.
    Janssen P; Harris MS; Jones M; Masaoka T; Farré R; Törnblom H; Van Oudenhove L; Simrén M; Tack J
    Am J Gastroenterol; 2013 Sep; 108(9):1382-91. PubMed ID: 24005344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of a single rectal dose of cisapride on delayed gastric emptying.
    Brummer RJ; Schoenmakers EA; Kemerink GJ; Heidendal GA; Sanders DG; Stockbrügger RW
    Aliment Pharmacol Ther; 1997 Aug; 11(4):781-5. PubMed ID: 9305489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Possibilities of ultrasonography of gastric emptying].
    Prassler R; Huchzermeyer H
    Wien Med Wochenschr; 1996; 146(24):615-8. PubMed ID: 9123948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical effects of STW 5 (Iberogast) are not based on acceleration of gastric emptying in patients with functional dyspepsia and gastroparesis.
    Braden B; Caspary W; Börner N; Vinson B; Schneider AR
    Neurogastroenterol Motil; 2009 Jun; 21(6):632-8, e25. PubMed ID: 19220753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic response to domperidone in gastroparesis: A prospective study using the GCSI-daily diary.
    Heckert J; Parkman HP
    Neurogastroenterol Motil; 2018 Jan; 30(1):. PubMed ID: 29110425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delayed gastric emptying during interferon-alpha therapy in patients with chronic hepatitis C: relief by cisapride.
    Nishibayashi H; Kanayama S; Shinomura Y; Kawata S; Matsuzawa Y
    Scand J Gastroenterol; 1997 Jun; 32(6):547-51. PubMed ID: 9200285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.